Report AMR

About AMR

The usage of antimicrobials causes bacteria or pathogens to change over time and makes antimicrobial pharmaceuticals less effective. This process is called antimicrobial resistance (AMR).

When AMR infections occur and antimicrobials become ineffective, these infections can in the worst cases be fatal. In Japan and overseas, more and more microbes are developing AMR. If the current situation continues unabated, the annual number of deaths due to AMR infections is projected to increase to about 10 million people globally by 2050.

HGPI issued calls for action on this issue and AMR Alliance Japan was established in November 2018 with the goal of driving discussions and promoting policies for AMR with representatives from industry, Government, academia, and civil society. In its role as secretariat of AMR Alliance Japan, HGPI works to formulate policy recommendations and to see those recommendations implemented.

[Research Report] The Public Opinion Survey on Global Health (August 22, 2022)
2022-08-22

[Research Report] The Public Opinion Survey on Global Health (August 22, 2022)>>

[Event Report] The Seventh Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (July 11, 2022)
2022-07-29

[Event Report] The Seventh Meeting of the AMR Consortium of the Nikkei FT Communicable D ...>>

[Event Report] Antimicrobial Resistance: A Future Global Health Crisis (January 13, 2022)
2022-06-20

[Event Report] Antimicrobial Resistance: A Future Global Health Crisis (January 13, 2022 ...>>

[In the Media] AMR Alliance Japan Presents Recommendations for the Basic Policy on Economic and Fiscal Management and Reform to Advance AMR Control (The Nikkan Yakugyo, May 30, 2022)
2022-06-10

[In the Media] AMR Alliance Japan Presents Recommendations for the Basic Policy on Econo ...>>

[Urgent Recommendation] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2022 (May 30, 2022)
2022-05-30

[Urgent Recommendation] Recommendation for the Basic Policy on Economic and Fiscal Manag ...>>

[Activity Report] Launch of New Website by AMED Public and Private Partnerships for Infectious Disease R&D (April 14, 2022)
2022-04-27

[Activity Report] Launch of New Website by AMED Public and Private Partnerships for Infe ...>>

[Activity Report] Himeji City becomes first municipality in Japan to issue declaration on the promotion of AMR countermeasures (February 21, 2022)
2022-04-25

[Activity Report] Himeji City becomes first municipality in Japan to issue declaration o ...>>

[Event Report] WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis” (September 25, 2021)
2022-04-13

[Event Report] WHO Regional Committee for the Western Pacific Related Event: “AMR: A Glo ...>>

[Case Study] Koji Masuda and Kenji Ikeda “TDM Is Not Only for Safety, but for Ensuring Effectiveness” (AMR Alliance Japan, March 31, 2022)
2022-03-31

[Case Study] Koji Masuda and Kenji Ikeda “TDM Is Not Only for Safety, but for Ensuring E ...>>

[Lived Experiences] Ms. Sachiko Ito – Non-Tuberculosis Mycobacterial Lung Disease (March 18, 2022)
2022-03-18

[Lived Experiences] Ms. Sachiko Ito – Non-Tuberculosis Mycobacterial Lung Disease ...>>

[Activity Report] Submission of recommendations to Public Comment on the “Interim Report of the Global Health Strategy in Japan Toward the 2030 Sustainable Development Goals (SDGs)” (February 25, 2022)
2022-03-17

[Activity Report] Submission of recommendations to Public Comment on the “Interim ...>>

[Case Study] Keisuke Kagami and Mitsuru Sugawara “Thrombocytopenia Can be Avoided By Monitoring Linezolid Blood Levels – Enabling Long-Term Linezolid Use for the Successful Treatment of Refractory Pyogenic Spondylodiscitis” (AMR Alliance Japan, March 7, 2022)
2022-03-07

[Case Study] Keisuke Kagami and Mitsuru Sugawara “Thrombocytopenia Can be Avoided By Mon ...>>

PageTop